Related Experiment Video
Updated: May 28, 2026
10:28
A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors
Published on: August 17, 2019
Limitations of conventional inhibitor classifications
Ryan Walsh1, Earl Martin, Sultan Darvesh
1Department of Chemistry, Carleton University, Ottawa, Ontario, Canada. rwalsh@connect.carleton.ca
Integrative Biology : Quantitative Biosciences From Nano to Macro
|November 1, 2011
Summary
Conventional enzyme inhibitor classifications are limited. This study proposes a new approach to enzyme activity modulation, offering a more accurate representation of kinetic data for better understanding enzyme inhibition.
Area of Science:
- Biochemistry
- Enzymology
Background:
- Enzyme inhibitors are typically classified as competitive, non-competitive, or mixed non-competitive.
- These classifications have limitations, describing only extreme inhibitory behaviors and excluding finite changes or simultaneous effects on kinetic parameters.
Purpose of the Study:
- To address the limitations of conventional enzyme inhibition equations.
- To propose an alternate approach for representing enzyme activity modulation.
- To provide a more accurate description of enzyme kinetic data.
Main Methods:
- Re-examination of conventional enzyme inhibition equations.
- Development of an alternate mathematical framework for enzyme activity modulation.
- Illustration using the competitive inhibition of Kallikrein by benzamidine.
Main Results:
- Conventional equations inadequately describe observed kinetic data due to conflating binding and effect terms.
- The proposed approach offers a more nuanced representation of enzyme inhibition.
- Demonstrated the limitations of existing models with Kallikrein-benzamidine inhibition.
Conclusions:
- Existing enzyme inhibitor classifications are insufficient for describing complex inhibitory behaviors.
- A revised approach is needed to accurately model enzyme inhibition, considering finite changes and combined effects.
- The proposed method enhances the understanding of enzyme-inhibitor interactions and kinetic data interpretation.
Related Concept Videos
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
02:34Enzymes
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
01:52Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
01:25Drug Classes and Categories
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...